MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Accuracy of preoperative microelectrode trajectory planning in patients treated with DBS – an ongoing study

    S. Ibrulj, S. Delalić, MB. Benedičič, D. Georgijev, DF. Flisar, M. Trošt (Ljubljana, Slovenia)

    Objective: To retrospectively analyze the accuracy of the preoperative Deep Brain Stimulation (DBS) trajectory planning based on final trajectories chosen with intraoperative neurophysiological testing and…
  • 2019 International Congress

    Assessment of occupationally exposed organic solvents and welding fumes induced DNA damage and SNPs (PARK13, LRRK2 and CAST gene) and risk of Parkinson’s disease

    K. Kalimuthu, R. Ramachndran, A. Arulsamy, S. Savariar (Annamalainagar, India)

    Objective: The aim of this study was to examine the potential association between solvents, welding fumes and SNPs and risk of developing PD. Background: The…
  • 2019 International Congress

    A case of osmotic demyelination syndrome presenting parkinsonism affected by blood alcohol concentration change

    M. Kondo, A. Unaki, T. Kimura (Tokyo, Japan)

    Objective: To describe a patient with osmotic myelinolysis caused by change in blood alcohol level who developed acute parkinsonism. Background: Osmotic myelinolysis is an acute,…
  • 2019 International Congress

    Genetics and phenotypes of recessive parkinsonism in French and North African populations

    S. Lesage, A. Lunati, M. Houot, S. Benromdhan, C. Tesson, F. Clot, C. Mhiri, E. Lohmann, JC. Corvol, A. Brice (Paris, France)

    Objective: To evaluate the mutation frequency in recessive genes and the associated phenotype in a large series of French and North African cases with Parkinson’s…
  • 2019 International Congress

    Acute parkinsonism following an obstructive hydrocephalus and a ventriculoperitoneal shunt revision: a case report

    J. Majuri, HR. Maanpää, A. Kotkansalo, J. Korpela, J. Joutsa (Lahti, Finland)

    Objective: To describe a case of acute parkinsonism following an obstructive hydrocephalus and ventriculoperitoneal (VP) shunt revision. Background: Acute parkinsonism is a rare complication of…
  • 2019 International Congress

    The role of the gut microbial dysbiosis and serum inflammatory profile for the discrimination of clinical subtypes in Parkinson’s disease

    I. Miliukhina, E. Ermolenko, E. Gracheva, A. Istomina, M. Kotyleva, E. Agapova, A. Suvorov (Saint-Petersburg, Russian Federation)

    Objective: To investigate whether clinical phenotypes can be predicted by the assessment of gut microbiome and serum inflammatory profile of PD patients. Background: Recent evidence…
  • 2019 International Congress

    Special features of parkinsonism with congenital anomalies of cerebral vessels

    AS. Norboboev, FAY. Odinaev, GUL. Rakhmatullaeva (Tashkent, Uzbekistan)

    Objective: To study the features of the flow of parkinsonism with congenital anomalies of cerebral vessels. Background: Analysis of the study of neurological status, data…
  • 2019 International Congress

    Liquid Levodopa/Carbidopa – An underutilized, cost effective treatment of advanced Parkinson’s disease in the developing world

    A. Panwar, N. Sawal (Chandigarh, India)

    Objective: Advanced Parkinson’s disease manifests with  “on-off” phenomenon, dyskinesias and increasing symptom severity . Managing it in developing countries is difficult given the low per…
  • 2019 International Congress

    The Progressive Supranuclear Palsy Functional Disability Scale: Sensitivity to change

    I. Piot, K. Schweyer, G. Respondek, M. Grimm, M. Stamelou, P. Sckopke, T. Schenk, C. Goetz, G. Stebbins, G. Höglinger (Munich, Germany)

    Objective: To determine the sensitivity to change within 12 months as well as completion time of the Progressive Supranuclear Palsy Functional Disability Scale (PSPFDS). Background:…
  • 2019 International Congress

    Validation of the Movement Disorder Society criteria for the diagnosis of 4R-tauopathies

    G. Respondek, MJ. Grimm, I. Piot, T. Arzberger, Y. Compta, E. Englund, LW. Ferguson, E. Gelpi, A. Giese, S. Roeber, DJ. Irwin, WG. Meissner, C. Nilsson, A. Pantelyat, A. Rajput, JB. Rowe, JC. van Swieten, C. Troakes, GU. Höglinger (London, United Kingdom)

    Objective: To validate the accuracy of the newly proposed Movement Disorder Society diagnostic criteria for progressive supranuclear palsy (MDS-PSP criteria, Höglinger et al., 2017) to…
  • « Previous Page
  • 1
  • …
  • 86
  • 87
  • 88
  • 89
  • 90
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley